【摘要】：創(chuàng)新能力對生物醫(yī)藥企業(yè)發(fā)展至關(guān)重要,本文嘗試將BP神經(jīng)網(wǎng)絡(luò)引入到生物醫(yī)藥上市公司的創(chuàng)新能力評價中,探究BP神經(jīng)網(wǎng)絡(luò)在醫(yī)藥產(chǎn)業(yè)創(chuàng)新能力評價中是否可行。采用文獻閱讀法,結(jié)合生物醫(yī)藥企業(yè)的實際情況,建立生物醫(yī)藥企業(yè)創(chuàng)新能力評價指標體系,利用統(tǒng)計學(xué)方法構(gòu)建相應(yīng)的BP神經(jīng)網(wǎng)絡(luò),將BP網(wǎng)絡(luò)輸出結(jié)果與期望輸出進行比較。采用已建立的創(chuàng)新能力評價指標體系并利用BP神經(jīng)網(wǎng)絡(luò)對生物醫(yī)藥企業(yè)的創(chuàng)新能力評價的輸出結(jié)果與期望輸出基本一致。將BP神經(jīng)網(wǎng)絡(luò)應(yīng)用于生物醫(yī)藥企業(yè)創(chuàng)新能力評價是可行的,所建立的創(chuàng)新能力評價指標體系基本能夠反映生物醫(yī)藥企業(yè)創(chuàng)新能力。
[Abstract]:Innovation ability is very important to the development of biomedical enterprises. This paper attempts to introduce BP neural network into the evaluation of innovation ability of listed biomedical companies, and to explore whether BP neural network is feasible in the evaluation of innovation ability of pharmaceutical industry. Based on the literature reading method and the actual situation of biomedical enterprises, the evaluation index system of innovation ability of biomedical enterprises is established, and the corresponding BP neural network is constructed by statistical method. The output results of BP network are compared with the expected output. The output results of innovation ability evaluation of biomedical enterprises are basically consistent with the expected output by using the established innovation ability evaluation index system and BP neural network. It is feasible to apply BP neural network to the evaluation of innovation ability of biomedical enterprises. The index system of innovation ability evaluation can basically reflect the innovation ability of biomedical enterprises.
【作者單位】： 中國藥科大學(xué)國際醫(yī)藥商學(xué)院;
【基金】：江蘇省“六大人才”高峰項目(YY-013)
【分類號】：F273.1;F426.72

【參考文獻】

相關(guān)期刊論文 前6條

1 齊秀輝;武志勇;;創(chuàng)新驅(qū)動視角下大中型工業(yè)企業(yè)創(chuàng)新能力動態(tài)綜合評價[J];科技進步與對策;2015年21期

2 徐立平;姜向榮;尹，

本文編號：2477027